Available with limitations
A blueprint is a starting set of documents, forms and tasks for a design such as a randomized trial, a diagnostic accuracy study or a device investigation. It is a draft. It is not an ethics approval and it is not validated for your protocol until your team reviews every field.
Randomized, observational, diagnostic, device, registry and decentralized starting points can be stored as drafts.
A site does not inherit a locked form. The team changes the draft to match the protocol.
Startup tasks can be included so they are not forgotten. They are not completed automatically.
A blueprint can remind the team which analysis belongs with the design. It does not run that analysis.
Using a blueprint still requires a person to confirm it matches the approved protocol.
A blueprint is not a regulator’s template and not a certified package.
The team picks the closest blueprint.
Names, visits and endpoints are changed to match the protocol.
A person signs the resulting definition.
Sites see the approved version.
No. Each study needs its own review.
Yes. A blueprint is optional.
Available with limitations means the described software behavior exists. A professional service is work a person does under a separate scope. Nothing here is a certification.
The conversation is about your study design and what the software can and cannot do today.
Clinical trial management for drugs, devices, and diagnostics. EU and US regulatory packages from one record. CAREPOI CRO, registered with EOF 16 November 2026.
© 2026 CAREPOI · ValidTrials · Helsinki, EU